FDA issues guidance on early feasibility trials for devices

10/4/2013 | Clinica (subscription required)

New guidance from the FDA outlines the information medtech manufacturers should supply to the agency when seeking investigational device exemption approval to carry out early feasibility trials. The guidance also details the requirements involving changes made to study protocols or device designs during the feasibility trial.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN